with a forward P/E of about 16, and PEG ratio a little above 1, perhaps
some will view BIIB as a biotech "value stock"?
To me the selling seemed extreme, so perhaps it'll see a reversal
of fortune on Monday....
For the record, I have never owned BIIB before Friday, when I bought in
4 increments as it dropped.